Partner Beth Boland has co-authored an Op-Ed for the Boston Globe, “As California bolts ahead, Mass. needs to catch up on boardroom diversity,” about the need for more women on the boards of directors of publicly traded companies in the state. The article cites a new California law requiring publicly traded companies headquartered there to include more women on their corporate boards, as well as similar requirements that have existed for more than a decade among many countries in Europe. If Massachusetts-based companies don’t move quickly to diversify on their own, the authors argue, the state legislature may be tempted to adopt mandatory measures based on the California model and the state may face a brain drain of its best and brightest women to California-based companies, particularly in the technology, manufacturing, retail, life sciences, and service sectors.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”